Evidence map›Paper›PMID 24861167›Full record

ArticleACS nano2014

Nanopore-based conformational analysis of a viral RNA drug target.

Carolyn Shasha, Robert Y Henley, Daniel H Stoloff, Kevin D Rynearson, Thomas Hermann, Meni Wanunu

Abstract read
In one paragraph

Article in ACS nano, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Supramolecular Interactions Modulate RNA:DNA Folding Observed via Nanopore Sensing.Angewandte Chemie (International ed. in English) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Real-time label-free detection of dynamic aptamer-small molecule interactions using a nanopore nucleic acid conformational sensor.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Synthetic heparan sulfate standards and machine learning facilitate the development of solid-state nanopore analysis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Article
  15. Review
  16. Construction of RNA nanotubes.Nano research · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Carolyn Shasha *Departments of Physics and Chemistry/Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
Robert Y Henley *Departments of Physics and Chemistry/Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
Daniel H StoloffDepartments of Physics and Chemistry/Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
Kevin D RynearsonDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Thomas HermannDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States.
Meni WanunuDepartments of Physics and Chemistry/Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Funding

New Antiviral Therapies for Hepatitis C InfectionR01AI072012 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HERMANN, THOMAS C · 2007 to 2011
$1.8M
Picogram-level DNA sequencing using Nanopores and Zero-Mode WaveguidesR21HG006873 · NHGRI · NORTHEASTERN UNIVERSITY · PI KORLACH, JONAS, WANUNU, MENI · 2012 to 2014
$812k
NHGRI NIH HHS R21 HG006873NIAID NIH HHS R01 AI072012
6 · The paper itself

Abstract

Nanopores are single-molecule sensors that show exceptional promise as a biomolecular analysis tool by enabling label-free detection of small amounts of sample. In this paper, we demonstrate that nanopores are capable of detecting the conformation of an antiviral RNA drug target. The hepatitis C virus uses an internal ribosome entry site (IRES) motif in order to initiate translation by docking to ribosomes in its host cell. The IRES is therefore a viable and important drug target. Drug-induced changes to the conformation of the HCV IRES motif, from a bent to a straight conformation, have been shown to inhibit HCV replication. However, there is presently no straightforward method to analyze the effect of candidate small-molecule drugs on the RNA conformation. In this paper, we show that RNA translocation dynamics through a 3 nm diameter nanopore is conformation-sensitive by demonstrating a difference in transport times between bent and straight conformations of a short viral RNA motif. Detection is possible because bent RNA is stalled in the 3 nm pore, resulting in longer molecular dwell times than straight RNA. Control experiments show that binding of a weaker drug does not produce a conformational change, as consistent with independent fluorescence measurements. Nanopore measurements of RNA conformation can thus be useful for probing the structure of various RNA motifs, as well as structural changes to the RNA upon small-molecule binding.

Indexed as

NanoporesRNA, ViralBinding SitesElectrodesElectrolytesFluorescence Resonance Energy TransferHepacivirusHydrogen-Ion ConcentrationMolecular ConformationNanoparticlesNanotechnologyNucleic Acid HybridizationRibosomesRNATemperatureElectrolytesRNARNA, Viral

Identifiers

PMID24861167
PMCPMC4729693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.